Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
54.00
-0.28 (-0.52%)
Mar 19, 2026, 3:57 PM EDT - Market open
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $7.77 billion as of March 19, 2026. Its market cap has decreased by -14.07% in one year.
Market Cap
7.77B
Enterprise Value
6.44B
1-Year Change
-14.07%
Ranking
Category
Stock Price
$54.00
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $7.77B, an increase of 463.18%. That is a compound annual growth rate of 35.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 7.81B | 29.34% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 9.01B |
| Praxis Precision Medicines | 8.32B |
| Bio-Techne | 8.19B |
| Axsome Therapeutics | 8.16B |
| Arrowhead Pharmaceuticals | 8.04B |
| Cytokinetics | 7.86B |
| Nuvalent | 7.74B |
| Halozyme Therapeutics | 7.50B |